How would Dexmedetomidine have Protective Effects on the Neurological Scores, Brain Edema and Brain-Blood Barrier Post to Serious Traumatic Brain Damage in Male Rats? (The Possible Role of MMP-9)
Journal Title: The 1st Annual Meeting of Georgian Center for Neuroscience Research - Year 2020, Vol 2, Issue 20
Abstract
Introduction: Dexmedetomidine DEX is known as a α2-adrenergic receptor agonist. It is used as a short-acting analgesic drug. In this study, we investigated the effects of neural protection of the DEX after induction of cerebral inflammation in rats. Materials and methods: The male Albino wistar rats received different doses of DEX (15, 30, 60 mg/kg, i.p.). All rats were intubated before TBI. In the TBI groups, diffuse TBI was induced by Marmarou method using a TBI induction device. The severe TBI was induced using a weight 300 gr. In the same groups, all stages of induction of TBI were performed except dropping weight on the head. The disruption of Blood brain- barrier (BBB) was evaluated 6 h post- TBI. The neurologic score (VCS) and brain water content, the beam-walk –balance task (WB) were determined before trauma, on trauma time(D0), and day 1 (D1) and Day 2 (D2) and Day 3 (D3) After TBI. after 72 hour CSF samples are collected from cisterna magna and then analysis mmp9 in CSF with Elisa assay. Results: Our results showed that traumatic brain injury led to significant brain edema and disrupt of blood brain- barrier and neurological defect and vestibular-motor dysfunction in the rat brain and increase mmp9 in CSF serum. DEX (15,30mg/kg) could attenuated brain edema, improved BBB, vestibular-motor dysfunction and decreased mmp9 in compare with TBI control group (P<0.001) but in 30mg/kg dose results were better and didn't have neuroprotective effect in 60mg/kg dose. Discussion: These findings showed that DEX has a prominent role in TBI outcome’s and perhaps protect neurons through modulating inflammatory and antioxidant pathways by inhibition of increasing intracellular calcium and decreasing mmp9 factor. By adding α2-adrenergic antagonist, neuroprotective effect of Dex has been disappeared. it indicates that a part of neuroprotective effect of DEX is through α2-adrenergic receptor.
Authors and Affiliations
Asal Safarbalou, Negar Mehrbakhsh, Mohaddese Shafiee Pour, Ali Siahposht Khachaki
Inhibition of Hippocampal Astrocytic Connexin-43 Reduces the Naloxone-Induced Withdrawal Signs in Morphine Dependent Rats
Background and Objective: Drug addiction is an ectopic form of learning, changes synaptic plasticity in various part of brain such as hippocampus. Morphine dependency cause a significant changes in the balance of excita...
Tau Protein in the Retina
Background: Recent research suggests that Tau is the culprit lesion along with neuroinflammation in the etiology of Alzheimer' s Disease (AD). Retina is the extention of the brain and is the most easily approachable par...
Evaluation of Neuronal Repair Process on Focal Demyelination Model of Multiple Sclerosis in Rat
Multiple sclerosis (MS) is one of the most autoimmune neurological and inflammatory disease in worldwide. Demyelination and disturbance of action potential conductance are regarded as main signs of MS disease. Hesperet...
The Relationship between Personality Traits, Psychological Capital and Mental Health
Background and purpose: Undoubtedly, mental health plays crucial role in the dynamics and efficiency of individuals in society. Many studies show that the more mental health we have, the less susceptible we are. One of...
Effect of Crocus Sativus (Saffron) on Patients Suffering from Chemotherapy-Induced Painful Peripheral Neuropathy in Semnan Kosar Hospital
Background and Objective: One of the most important side effects of chemotherapy drugs is peripheral neuropathy, which is characterized by symptoms such as numbness, paresthesia, dysstasy, tingling or numbness of the li...